The first possible scientifically proven treatment for COVID-19 emerged Wednesday with early data from a global study finding patients given the experimental drug Remdesivir recovered faster and may be less likely to die.
Early results released from the global study conducted by the U.S. National Institute of Allergy and Infectious Diseases found patients who received Remdesivir had a 31% faster recovery time than those who received a placebo.
While not a "knock out," NIAID director Anthony Fauci said at an Oval Office meeting Wednesday, the study results were "a very important proof of concept."
Earlier Wednesday, pharmaceutical company Gilead Sciences said Remdesivir produced "similar improvement" in patients over a 10-day treatment plan compared with a five-day treatment plan.
0 Comments
The views expressed herein are those of the presenter; they do not reflect the views of Naijazee or any of it's employees
Emoji